期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

乳腺癌疫苗的研究进展 被引量：2

原文传递
导出
摘要 乳腺癌在欧美国家及我国部分大城市已占女性恶性肿瘤的首位，目前常用的治疗方式包括手术、化疗、放疗、内分泌治疗以及分子靶向治疗等。伴随着免疫科学的发展，免疫治疗成为乳腺癌治疗研究的新领域。
作者 张晓辉 孙强
机构地区 中国医学科学院 北京协和医学院 北京协和医院乳腺外科
出处 《中华临床医师杂志（电子版）》 CAS 2012年第12期134-135,共2页 Chinese Journal of Clinicians(Electronic Edition)
关键词 乳腺癌 癌疫苗 女性恶性肿瘤 分子靶向治疗 治疗方式 免疫治疗 内分泌治疗 欧美国家
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献21

  • 1Finn OJ. Cancer Immunology[J].New England Journal of Medicine,2008.2704-2715.
  • 2Palucka K,Ueno H,Banchereau J. recent developments in cancer Vaccines[J].Journal of Immunology,2011.1325-1331.
  • 3Banchereau J,Plucka K. Dendritic cells as therapeutic vaccines against cancer[J].Nature Immunology,2005,(4):296-306.doi:10.1038/nri1592.
  • 4Mittendorf EA,Holmes JP,Ponniah S. The E75 HER2/neu peptide vaccine[J].Cancer Immunology Immunotherapy,2008.1511-1521.
  • 5Svane IM,Pedersen AE,Johnsen HE. Vaccination with p53-peptide-pulsed dendritic cells,of patients with advanced breast cancer:report from a Phase I study[J].Cancer Immunology Immunotherapy,2004.633-641.
  • 6Disis ML,Gooley TA,Rinn K. Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines[J].Journal of Clinical Oncology,2002,(11):2624-2632.doi:10.1200/JCO.2002.06.171.
  • 7Disis ML,Wallace DR,Gooley TA. Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer[J].Journal of Clinical Oncology,2009.4685-4692.
  • 8Jaini R,Kesaraju P,Johnson JM. An autoimmune-mediated strategy for prophylactic breast cancer vaccination[J].Nature Medicine,2010.799-803.
  • 9Emens LA,Asquith JM,Leatherman JM. Timed sequential treatment with cyclophosphamide,doxorubicin,and an allogeneic granulocyte-macrophage colony-stimulating factor-secreting breast tumor vaccine:a chemotherapy dose-ranging factorial study of safety and immune activation[J].Journal of Clinical Oncology,2009.5911-5918.
  • 10Reed E,Cowan K,Gabrilovich D. Autologous dendritic cellvaccine directed at wild type p53 in patients with high-risk breast cancertreated with adjuvant chemotherapy[A].San Antonio,Texas,USA,2008.2152.

二级参考文献22

  • 1江文正,金宁一,李子健,张立树,王宏,金洪涛.IL-18和HIV-1gag-gp120嵌合基因DNA疫苗联合免疫小鼠的免疫应答[J].细胞与分子免疫学杂志,2004,20(4):433-435. 被引量：7
  • 2崔保安,魏战勇,王学斌,黄克和,金喜新,董振杰,郑兰兰.IL-2与猪细小病毒VP_2基因双表达载体的构建及免疫原性的研究[J].生物工程学报,2006,22(3):425-430. 被引量：11
  • 3胡敏,陈光宇.细胞因子作为DNA疫苗佐剂的研究进展[J].生物技术通讯,2007,18(3):480-482. 被引量：6
  • 4Qiu H,Fan Y,Joyee AG, et al.Type I IFNs enhance susceptibility to Chlamydia muridarum lung infection by enhancing apoptosis of local macrophages. J Immunol . 2008
  • 5Sin JI,Kim JJ,Ugen KE. et al.Enhancement of protective humoral(Th2) and cell-mediated (Th1) immune responses against herpes simplexvirus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes. European Journal of Immunology . 1998
  • 6R S. Kombluthl,and G W. Stone.Immunostimulatory combinations: designing the next generation of vaccine adjuvants. Journal of Leukocyte Biology . 2006
  • 7Zhou X,Jun do Y,Thomas AM,et al.Diverse CD8+ T-cell responses to renal cell carcinoma antigens in patients treated with an autologous granulocyte-macrophage colony-stimulating factor gene-transduced renal tumor cell vaccine. Cancer Research . 2005
  • 8Kusakabe K,Xin KQ,Katoh H,et al.The timing of GM-CSF expression plasmid administration influences the Th1/Th2 response induced by an HIV-1-specific DNA vaccine. Journal of Immunology . 2000
  • 9Biragyn A,Belyakov I M,Chow Y H,et al.DNA vaccines encoding human immunodeficiency virus-1 glycoprotein 120 fusions with proinflammatory chemoattractants induce systemic and mucosal immune responses. Blood . 2002
  • 10Xin KQ,Lu Y,Hamajima K,et al.Immunization of RANTES expression plasmid with a DNA vaccine enhances HIV-1-specific immunity. Clinical Immunology . 1999

共引文献1

同被引文献2

引证文献2

二级引证文献12

中华临床医师杂志（电子版）
2012年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部